Skip to main content

Table 1 Patient clinical characteristics

From: [177Lu]Lu-DOTA-ZOL bone pain palliation in patients with skeletal metastases from various cancers: efficacy and safety results

Variables Number (%)
Age in years (mean ± SD, range) 46.6 ± 15.08 (24–78)
Gender
 Male 15 (37.5%)
 Female 25 (62.5%)
Primary disease
 Prostate 11 (27.5%)
 Breast 23 (57.5%)
 Lung 6 (15%)
Baseline VAS pre-therapy (median, IQR) 9 (8–10)
Baseline KPS pre-therapy (median, IQR) 60 (50–70)
Baseline analgesic score (median) 6 (6–8)
The extent of skeletal metastases
 < 6 2 (5%)
 6–20 17 (42.5%)
 > 20 7 (17.5%)
Diffuse/superscan 14 (35%)
ECOG performance status
 2 12 (30%)
 3 15 (37.5%)
 4 13 (32.5%)
Mean cumulative activity (GBq) 2.1 ± 0.6 GBq (1.3–2.7 GBq)
  1. IQR inter-quartile range, VAS visual analogue score, KPS Karnofsky performance status, ECOG Eastern Cooperative Oncology Group, GBq gigabecquerel